Browsed by
Month: March 2018

Mark Zuckerberg and the Apology Algorithm

Mark Zuckerberg and the Apology Algorithm

It took Mark Zuckerberg a few days before issuing an apology over the Cambridge Analytica hack. Odd, considering how much practice he has had over the years:

2007: Zuckerberg Saves Face, Apologizes For Beacon. To refresh your memory, Beacon was an intrusive, controversial ad system that compromised consumer privacy. “We’ve made a lot of mistakes building this feature, but we’ve made even more with how we’ve handled them. We simply did a bad job with this release, and I apologize for it,” Zuckerberg wrote. “Instead of acting quickly, we took too long to decide on the right solution. I’m not proud of the way we’ve handled this situation and I know we can do better.” Oops, sorry. And nothing more to see here. As TechCrunch noted, (Zuckerberg) “also announced a new privacy control that lets Facebook members opt out of Beacon completely. Before, you had to opt out on a case-by-case and site-by-site basis… Maybe Zuckerberg is finally beginning to realize that he does not have permission to track his customers indiscriminately across the Web. Nobody does anymore.” Read More...

The Theranos Effect: The Bewitched, Bothered and Bewildered Edition

The Theranos Effect: The Bewitched, Bothered and Bewildered Edition

This past week, Theranos founder and Steve Jobs wannabe Elizabeth Holmes was charged with “massive fraud” by the Securities and Exchange Commission. She agreed to pay a $500,000 penalty, be barred from serving as an officer or director of a public company for 10 years, and returned 18.9 million shares she amassed during the alleged fraud.

The company, which raised more than $700M in funding, was “deceiving investors by making it appear as if Theranos had successfully developed a commercially-ready portable blood analyzer” that could perform a full range of laboratory tests from a small sample of blood…But in reality, we allege that after years of development, Theranos was able to process just a small number of blood tests upon its proprietary analyzer, and instead conducted the vast majority of its patients’ tests on modified commercial analyzers that were manufactured by others,” Steven Peikin, the SEC’s co-director of enforcement, told reporters, according to USA Today. Read More...

No is an Acronym

No is an Acronym

Investors hate to say no. They like to hedge their bets and keep their options open. But they will sometimes give you a hard and fast No. Still, that said, things change, so one never knows if it truly is a hard No.

For example, take Avner Ronan, founder of Boxee, a cross-platform freeware media center with social networking features that eventually spun out the Boxee Box. Et al, but more on that later. When he was going for funding, Ronen decided that Fred Wilson would be the perfect investor for Boxee, so he targeted Fred and did get the meeting, but Wilson said No. Undeterred, Ronen continued to send Wilson monthly update on their pivots and progress. The answer continued to come back as No. This went on for 18 months, until there came that one update that changed everything. Finally, Fred said ‘Yes!’ Read More...

Beware the Tech Cartel and People Who Speak in Code

Beware the Tech Cartel and People Who Speak in Code

We follow Max Levchin on Twitter. Last week, he posted an interesting series of tweets, based on an Edelman Trust Barometer Report that was released at the World Economic Forum in Davos in January.

For the record, Levchin was co-founder and CTO of Paypal; former Chairman of Yelp; founder/CEO of Slide (acquired by Google and shut down); currently, founder of Affirm, and a long-time WEF attendee. Read More...